Erwei Zuo

3.4k total citations · 3 hit papers
35 papers, 1.9k citations indexed

About

Erwei Zuo is a scholar working on Molecular Biology, Genetics and Plant Science. According to data from OpenAlex, Erwei Zuo has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Genetics and 5 papers in Plant Science. Recurrent topics in Erwei Zuo's work include CRISPR and Genetic Engineering (29 papers), RNA regulation and disease (8 papers) and RNA and protein synthesis mechanisms (8 papers). Erwei Zuo is often cited by papers focused on CRISPR and Genetic Engineering (29 papers), RNA regulation and disease (8 papers) and RNA and protein synthesis mechanisms (8 papers). Erwei Zuo collaborates with scholars based in China, United States and Germany. Erwei Zuo's co-authors include Yidi Sun, Yixue Li, Wenqin Ying, Tanglong Yuan, Hui Yang, Wei Wu, Hao Sun, Liyun Yuan, Lars M. Steinmetz and Hui Yang and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Erwei Zuo

33 papers receiving 1.8k citations

Hit Papers

Cytosine base editor generates substantial off-target sin... 2019 2026 2021 2023 2019 2019 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erwei Zuo China 18 1.7k 505 207 171 105 35 1.9k
Julian Grünewald United States 9 1.6k 0.9× 454 0.9× 228 1.1× 163 1.0× 108 1.0× 11 1.6k
Yidi Sun China 18 1.5k 0.9× 433 0.9× 167 0.8× 146 0.9× 106 1.0× 39 1.7k
Kayeong Lim South Korea 14 1.7k 1.0× 521 1.0× 209 1.0× 141 0.8× 83 0.8× 20 1.8k
Heon Seok Kim South Korea 14 1.7k 1.0× 471 0.9× 175 0.8× 217 1.3× 96 0.9× 24 1.9k
Eunji Kim South Korea 11 1.7k 1.0× 424 0.8× 214 1.0× 220 1.3× 66 0.6× 28 1.9k
Luhan Yang United States 9 2.0k 1.2× 605 1.2× 225 1.1× 217 1.3× 61 0.6× 12 2.3k
Wenqin Ying China 16 1.2k 0.7× 384 0.8× 130 0.6× 113 0.7× 58 0.6× 17 1.3k
Chris D. Richardson United States 9 1.7k 1.0× 398 0.8× 151 0.7× 175 1.0× 79 0.8× 14 1.7k
H. Steve Zhang United States 4 1.7k 1.0× 542 1.1× 229 1.1× 109 0.6× 85 0.8× 6 1.9k
Siyuan Tan United States 10 1.7k 1.0× 510 1.0× 263 1.3× 115 0.7× 51 0.5× 22 2.0k

Countries citing papers authored by Erwei Zuo

Since Specialization
Citations

This map shows the geographic impact of Erwei Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwei Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwei Zuo more than expected).

Fields of papers citing papers by Erwei Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwei Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwei Zuo. The network helps show where Erwei Zuo may publish in the future.

Co-authorship network of co-authors of Erwei Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Erwei Zuo. A scholar is included among the top collaborators of Erwei Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwei Zuo. Erwei Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Guoling, Xue Dong, Jiamin Luo, et al.. (2024). Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation. Nature Communications. 15(1). 8090–8090. 6 indexed citations
3.
Yin, Lijuan, Chikai Zhou, Bo Qu, et al.. (2024). Chromosome-level genome of Ambrosia trifida provides insights into adaptation and the evolution of pollen allergens. International Journal of Biological Macromolecules. 259(Pt 2). 129232–129232. 1 indexed citations
4.
Yan, Nana, Feng Hu, Ying Xin, et al.. (2023). Cytosine base editors induce off-target mutations and adverse phenotypic effects in transgenic mice. Nature Communications. 14(1). 1784–1784. 21 indexed citations
5.
Chen, Qinchang, Guohui Chuai, Huan Guan, et al.. (2023). Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints. Nature Communications. 14(1). 7521–7521. 36 indexed citations
6.
Yan, Zixiang, Yuqin Yao, Luyao Li, et al.. (2023). Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice. Molecular Therapy — Nucleic Acids. 33. 750–761. 14 indexed citations
7.
Lin, Qiupeng, Zixin He, Hu Xu, et al.. (2023). Discovery of deaminase functions by structure-based protein clustering. Cell. 186(15). 3182–3195.e14. 132 indexed citations breakdown →
8.
Gao, Yanxia, Kailun Fang, Zixiang Yan, et al.. (2022). Develop an efficient and specific AAV-based labeling system for Muller glia in mice. Scientific Reports. 12(1). 22410–22410. 9 indexed citations
9.
Li, Guoling, Ming Jin, Zhifang Li, et al.. (2022). Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy. Journal of Clinical Investigation. 133(3). 30 indexed citations
10.
Zhang, Jinfu, Hussein M. Abkallo, Yuan Zhou, et al.. (2021). The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research. Journal of genetics and genomics. 48(5). 347–360. 14 indexed citations
11.
Yuan, Tanglong, Nana Yan, Juan Meng, et al.. (2021). Optimization of C-to-G base editors with sequence context preference predictable by machine learning methods. Nature Communications. 12(1). 4902–4902. 39 indexed citations
12.
Abdelnour, Sameh A., et al.. (2021). The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases. Frontiers in Cell and Developmental Biology. 9. 699597–699597. 65 indexed citations
13.
Zuo, Erwei, Yidi Sun, Wei Wu, et al.. (2020). GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos. Nature Protocols. 15(9). 3009–3029. 28 indexed citations
14.
Ding, Ning, Yidi Sun, Tanglong Yuan, et al.. (2020). Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effects. Science Advances. 6(29). eaba1773–eaba1773. 64 indexed citations
15.
Zuo, Erwei, Yidi Sun, Tanglong Yuan, et al.. (2020). A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects. Nature Methods. 17(6). 600–604. 106 indexed citations
16.
Zuo, Erwei, Yidi Sun, Wei Wu, et al.. (2019). Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science. 364(6437). 289–292. 555 indexed citations breakdown →
17.
Wei, Wei, Hong Pan, Junyu Nie, et al.. (2019). Identification of the Sex of Pre-implantation Mouse Embryos Using a Marked Y Chromosome and CRISPR/Cas9. Scientific Reports. 9(1). 14315–14315. 5 indexed citations
18.
Zuo, Erwei, Xuan Yao, Xinde Hu, et al.. (2017). CRISPR/Cas9-mediated targeted chromosome elimination. Genome biology. 18(1). 224–224. 139 indexed citations
19.
Zhang, Wenxin, Erwei Zuo, Ying He, et al.. (2016). Promoter structures and differential responses to viral and non-viral inducers of chicken melanoma differentiation-associated gene 5. Molecular Immunology. 76. 1–6. 9 indexed citations
20.
Liu, Hongbo, Xiangxing Zhu, Xianwei Wang, et al.. (2014). In vitro development of porcine transgenic nuclear-transferred embryos derived from newborn Guangxi Bama mini-pig kidney fibroblasts. In Vitro Cellular & Developmental Biology - Animal. 50(9). 811–821. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026